Gilead Sciences

• Headlines

U.S. Gains COVID-19 Drug Monopoly for Gilead’s 31,900% Markup

July 1, 2020

• Headlines

Gilead Sciences Stock Is Rallying – And the Reason Why May Sicken You

June 29, 2020

• Markets News & Opinions

The Stock Market Is Insane to Rally on Gilead’s Flimsy Remdesivir Study

April 29, 2020

• Markets News & Opinions

Why Your Favorite ‘Coronavirus Stock’ Just Took Wall Street on a Nasty Ride

April 23, 2020

• Markets News & Opinions

Dow Swings Wildly After Trial ‘Flop’ Ignites Coronavirus Drug Fears

April 23, 2020

• Markets News & Opinions

This Is Why the Dow Jones Soared While Its 2 Biggest Stocks Dove

April 17, 2020

• Markets News & Opinions

Why It’s Too Early to Celebrate Gilead Sciences’ Coronavirus Therapy

April 17, 2020